MSN Home  |  My MSN  |  Hotmail
Sign in to Windows Live ID Web Search:   
go to MSNGroups 
Free Forum Hosting
 
Important Announcement Important Announcement
The MSN Groups service will close in February 2009. You can move your group to Multiply, MSN’s partner for online groups. Learn More
askjoel[email protected] 
  
What's New
  
  AskJoel  
  Ask Joel  
  Questions/Answers  
  Prior Questions  
  Who is Joel?  
  Joel's Library  
  Links  
  No Medical Advice  
  Joel's Videos  
  
  
  Tools  
 
General : Brain chemical flow after quitting  
     
Reply
 Message 1 of 5 in Discussion 
From: John  (Original Message)Sent: 5/8/2006 7:51 PM
Hello,
 
I understand that nicotine addiction causes alterations in the user's brain.  My question is:  Will my brain ever start producing and utilizing chemicals as if it would have if I had never smoked? 
 
Thank you!
 
Amy


First  Previous  2-5 of 5  Next  Last 
Reply
 Message 2 of 5 in Discussion 
From: JohnSent: 5/8/2006 8:18 PM
Amy, generally, yes but, as Joel likes to say, with aging thrown in.  The science in this area is really just now unfolding.  I'll locate and attach below some of what I've read. 
 
But we have to keep in mind that our brain function immediately after being hit with a flood of new nicotine, or when being deprived of nicotine for substantial periods of time, would not be our natural neurochemical levels.  "Home" is obviously somewhere between the nicotine high and low.
 
It's also obvious that once wired for nicotine that some changes due to dependency onset likely remain for life, and would account for the ex-smoker's relapse potential,  returning them to their old level of nicotine intake and often higher.  This is an area of study now receiving attention.  Another question is how long it takes to restore neuronal sensitivities.  Everything I've read suggests that the brain's down-regulation of acetylcholine receptor sites is rather quick. 
 
I don't know where you are timing wise in recovery, Amy, but I can tell you that the sense of mental quiet and calm that arrives is wonderful.  Also, the calm during crisis, in not having a stressful acid producing event within the body's fluids neutralize reserves of the alkaloid nicotine, thus adding early withdrawal to every stressful event, is nice. 
 
Millions of words but eventually just one guiding principle for all, no nicotine today, Never Take Another Puff! 
 
Breathe deep, hug hard, live long,
 
John
 
 

Reply
 Message 3 of 5 in Discussion 
From: JohnSent: 5/8/2006 8:22 PM
 
 
Is Smoking Cigarettes Addictive?
 

50 million Americans smoke cigarettes. In the face of clear evidence that cigarettes cause lung cancer, outlined in a previous article in this series, why don’t smokers quit? Many of these individuals say they would like to, but can’t; they simply find it too difficult to overcome the habit. Anyone who has ever smoked cigarettes knows how difficult it is to quit. Most studies indicate a “quitting�?success rate -- at least two year’s abstinence -- of about 20 percent. Despite this widespread experience, cigarette manufacturers have steadfastly refused to admit that smoking cigarettes is addictive, even swearing so under oath before congress last year. However, the maker of Chesterfield cigarettes, Liggett, has recently broken ranks  with the other tobacco companies and in a legal settlement agreed that cigarettes cause cancer and are addictive. A tobacco spokesperson, addressing the question in the wake of the Liggett settlement, quibbled that the question has no answer, as addiction means different things to different people. Who is right? Is nicotine, the key  ingredient, an addictive drug?

How Psychoactive Drugs Affect the Brain

To understand the nature of addiction, you must focus your attention on how nerves in the brain communicate with one another, because it is in altering this process that chemicals like nicotine have their effect. Unlike electrical wires in a house, the nerve cells in the brain are not physically connected to one another. They are separated from one another by tiny gaps. For a signal to pass from one nerve cell to another within the brain, it must cross the space that separates the two cells. How is this achieved? By shooting chemicals across the gap! Called neurotransmitters, these chemicals bind to specific receptor proteins embedded within the cell membrane on the far side of the gap. The binding of a neurotransmitter to a matching stimulatory receptor promotes the generation of a new signal in the receiving nerve cell, thus successfully transferring the signal across the gap.

Investigators studying mind-altering drugs soon learned that mood, pleasure, and other mental states are determined by particular groups of nerves in the brain that use special sets of neurotransmitters and receptors. Much of the early work was driven by attempts to understand and treat depression. Researchers found that the mood-elevating nerve pathways of depressed individuals appeared to have too little of the neurotransmitter seratonin to function effectively. With too little seratonin in the gaps between nerve cells, the target receptors on the receiving nerve cells don’t fire enough to keep the mood-elevating pathway active, and depression results. Attempts to treat depression by administering extra seratonin failed -- there were too many side effects.

Success was finally achieved with drugs that magnify the effects of the seratonin molecules already present. After each seratonin molecule has had a chance to transmit the signal across the gap by hitting a target receptor, it is either destroyed or reabsorbed by the nerve cell that released it. Antidepressant drugs like Prozac (c) block the reabsorption of seratonin. If it is not removed from the gap, the seratonin neurotransmitter molecules just keep smashing into receptors on the far side, triggering them to fire the nerve cell receiving the signal again and again.

From this research into depression a general rule emerged: Mind-altering drugs often work by prolonging the time the neurotransmitter persists in the gaps between nerves. They increase the number of “hits�?of target receptors by simply allowing the neurotransmitter molecules to keep on shooting. Just as in a basketball game, the score increases if the game goes into overtime.

Search for the Chemical Nature of Addiction

The deep lesson learned from the studies of depression is that it is possible to understand mind-altering events in the brain at a molecular level. Part of a wave of research into the chemistry of the brain in recent decades, it sparked new investigations into many problems, one of them the chemical nature of drug addiction.

An immediate focus of research was the highly addictive drug cocaine. Cocaine affects nerve cells of the brain’s pleasure pathways (the so-called limbic system). These cells transmit pleasure messages using the neurotransmitter dopamine. Each cell communicates with the next by releasing dopamine into the gap, like pellets from a shotgun blast; the cell receiving the signal possess targets (the receptor proteins) that the pellets hit. The more receptor targets present on the surface of the receiving cell, the more likely a hit will occur, passing the signal to the receiving cell.

Investigators soon learned how cocaine stimulates the pleasure pathways to increase their rate of firing. Using radioactively-labelled cocaine molecules, they found that cocaine binds tightly to the carrier proteins in the gap between nerves that normally removes the neurotransmitter dopamine after it has acted. Like a game of musical chairs in which all the chairs become occupied, there are no unoccupied carrier proteins available to the dopamine molecules, so they stay in the gap, firing the receptors again and again. As new signals arrive, more and more dopamine is added, firing the pleasure pathway more and more often.

When the cells of your body are exposed to chemical signals for a prolonged period of time, they tend to loose their ability to respond to the stimulus with its original intensity. When you put on a wristwatch, how long are you aware you are wearing it? Nerve cells are particularly affected by this sort of loss of sensitivity. When receptor proteins on limbic system nerve cells are exposed to high levels of dopamine neuro- transmitter molecules for prolonged periods of time, the nerve cells “turn down the volume�?of the signal by lowering the number of receptor proteins on their surfaces. They respond to the greater number of neurotransmitter molecules by simply reducing the number of targets available for these molecules to hit, a feedback process that is a normal part of the functioning of all nerve cells. The cocaine user is now addicted. With so few receptors, the user needs the drug to maintain even normal levels of limbic activity.

Is Nicotine an Addictive Drug?

Investigators attempting to explore the habit-forming nature of nicotine used what had been learned about cocaine to carry out what seems a reasonable experiment -- they introduced radioactively-labelled nicotine into the brain and looked to see what sort of carrier protein it attached itself to. To their great surprise, the nicotine ignored proteins in the between-cell gaps and instead bound directly to a specific receptor on the receiving nerve cell surface! This was totally unexpected, as nicotine does not normally occur in the brain -- why should it have a receptor there?

Intensive research followed, and researchers soon learned that the “nicotine receptors�?were in fact designed to bind the neurotransmitter acetylcholine, and it was just an accident of nature that nicotine, an obscure chemical from a tobacco plant, was also able to bind to them. What then is the normal function of these receptors? The target of considerable research, these receptors turn out to be one of the brain’s most important tools. The brain uses them to coordinate the activities of many other kinds of receptors, acting to “fine tune�?the sensitivity of a wide variety of behaviors.

When neurobiologists compare the limbic system nerve cells of smokers to those of nonsmokers, they find changes in both the number of nicotine receptors and in the levels of RNA used to make the receptors. They have found that the brain adjusts to prolonged exposure to nicotine by “turning down the volume�?in two ways: 1. by making fewer receptor proteins to which nicotine can bind; 2. by altering the pattern of activation of the nicotine receptors (that is, their sensitivity to neurotransmitter).

It is this second adjustment that is responsible for the profound effect smoking has on the brain’s activities. By overriding the normal system used by the brain to coordinate its many activities, nicotine alters the pattern of release into gaps between nerve cells of many neurotransmitters, including acetylcholine, dopamine, serotonin, and many others. As a result, changes in level of activity occur in a wide variety of nerve pathways within the brain.

Addiction occurs when chronic exposure to nicotine induces the nervous system to adapt physiologically. The brain compensates for the many changes induced by nicotine by making other changes. Adjustments are made to the numbers and sensitivities of many kinds of receptors within the brain, restoring an appropriate balance of activity.

Now what happens if you stop smoking? Everything is out of whack! The newly coordinated system requires nicotine to achieve an appropriate balance of nerve pathway activities. This is addiction in any sensible use of the term. The body’s physiological response is profound and unavoidable. There is no way to prevent addiction to nicotine with willpower, any more than willpower can stop a bullet when playing Russian roulette with a loaded gun. If you smoke cigarettes for a prolonged period, you will become addicted.

Quitting Smoking

So what do you do, if you are addicted to smoking cigarettes and you want to stop? When use of an addictive drug like nicotine is stopped, the level of signaling along the many affected pathways will change to levels far from normal. If the drug is not reintroduced, the altered level of signalling will eventually induce the nerve cells to once again make compensatory changes that restore an appropriate balance of activities within the brain. Over time, receptor numbers, their sensitivity, and patterns of release of neurotransmitters all revert to normal, once again producing normal levels of signalling along the pathways. There is no way to avoid the down side. The pleasure pathways will not function at normal levels until the number of receptors on the affected nerve cells have time to readjust.

Many people attempting to quit smoking use patches containing nicotine to help them, the idea being that providing nicotine removes the craving for cigarettes. This is true, it does -- so long as you keep using the patch. Actually, using such patches simply substitutes one (admittedly less dangerous) nicotine source for another. If you are going to quit smoking, there is no way to avoid the necessity of eliminating the drug to which you are addicted, nicotine. Hard as it is to hear the bad news, there is no easy way out. The only way to quit is to quit. 

©Txtwriter Inc.

Link to original article at On Science website: http://www.txtwriter.com/Onscience/Articles/addictive.html

ON SCIENCE articles are the copyright of Txtwriter Inc. All rights reserved.


Reply
 Message 4 of 5 in Discussion 
From: JohnSent: 5/8/2006 8:31 PM
  
Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine.

Neuroscience. 2006;137(2):565-72. Epub 2005 Nov 14.



Mugnaini M, Garzotti M, Sartori I, Pilla M, Repeto P, Heidbreder CA, Tessari M.

Biology Department, Psychiatry-CEDD, GlaxoSmithKline S.p.A., Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy. [email protected]

Prolonged exposure to nicotine, as occurs in smokers, results in up-regulation of all the neuronal nicotinic acetylcholine receptor subtypes studied so far, the only differences residing in the extent and time course of the up-regulation. alpha6beta2*-Nicotinic acetylcholine receptors are selectively enriched in the mesostriatal dopaminergic system and may play a crucial role in nicotine dependence. Here we show that chronic nicotine treatment (3mg/kg/day for two weeks, via s.c. osmotic minipumps) caused a significant decrease (36% on average) in the binding of [(125)I]Y(0)-alpha-conotoxin MII (a selective ligand for alpha6beta2*-nicotinic acetylcholine receptors in this system) to all the five regions of the rat dopaminergic pathway analyzed in this study.
 
After one week of withdrawal, binding was still lower than control in striatal terminal regions (namely the caudate putamen and the accumbens shell and core). In somatodendritic regions (the ventral tegmental area and the substantia nigra) the decrease was significant at the end of the treatment and recovered within one day of withdrawal. This effect was not due to displacement of [(125)I]Y(0)-alpha-conotoxin MII binding by residual nicotine. In fact the binding was not changed by 565 ng/g nicotine (obtained with a single injection of nicotine), a concentration much higher than that found in the brain of rats chronically treated with nicotine (240 ng/g).
 
In addition, consistent with previous studies reporting an up-regulation of other subtypes of nicotinic acetylcholine receptors, we found that nicotine exposure significantly increased (40% on average) the binding of [(125)I]epibatidine (a non-selective agonist at most neuronal heteromeric nicotinic acetylcholine receptors) in three up to five regions containing only alpha-conotoxin MII-insensitive [(125)I]epibatidine binding sites, namely the primary motor, somatosensory and auditory cortices.
 
In conclusion, this work is the first to demonstrate that alpha6beta2*-nicotinic acetylcholine receptors, unique within the nicotinic acetylcholine receptor family, are down-regulated following chronic nicotine treatment in rat dopaminergic mesostriatal pathway, a finding that may shed new light in the complex mechanisms of nicotine dependence.

PMID: 16289885 [PubMed - indexed for MEDLINE]
 

Reply
 Message 5 of 5 in Discussion 
From: JohnSent: 5/8/2006 8:47 PM

Below is one quoted paragraph from the below referenced study.


 

Comorbid Tobacco Dependence
and Psychiatric Disorders

By Andrea H. Weinberger, Ph.D., M.A., Kristi A. Sacco, Psy.D., M.A., and Tony P. George, M.D.

Psychiatric Times January 2006 Vol. XXV Issue 1
 
 
Nicotine stimulates the release of several neurotransmitter systems, including dopamine, norepinephrine, 5-hydroxytryptamine (5-HT), glutamate, γ-aminobutyric acid (GABA) and endogenous opioid peptides, and acts as an agonist on presynaptic nicotinic acetylcholine receptors (nAChRs), which are stimulated endogenously by acetylcholine (Mansvelder and McGehee, 2002; Picciotto, 2003). Although chronic exposure of agonists typically produces receptor downregulation, chronic nicotine administration causes a paradoxical upregulation of nAChRs through rapid desensitization followed by receptor inactivation (Gentry and Lukas, 2002). After a short period of abstinence (e.g., overnight), nAChRs are resensitized and once again responsive to nicotine. This may explain why many smokers tend to report the first cigarette of the morning as their most satisfying.
 
Online source: 
 
 
Copyright © 2006 CMP Healthcare Media Group LLC

First  Previous  2-5 of 5  Next  Last 
Return to General